🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Neoplasms, Malignant

An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study NCT06855706NA1 site📍 Buffalo Roswell Park Cancer Institute · Tests: Behavioral Intervention, Best Practice, Biospecimen Collection, Electronic Health Record Review, Exercise Intervention Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy NCT05903833Phase 215 sites📍 Augsburg📍 Bad Homburg📍 Dresden AGO Research GmbH · Tests: Pembrolizumab, Lenvatinib BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) NCT04752826Phase 1, Phase 225 sites📍 Duarte📍 New York📍 Philadelphia BioInvent International AB · Tests: BI-1808, Pembrolizumab (KEYTRUDA® ) 25 Mg/mL Solution for Injection, Paclitaxel 80 mg/m2 weekly Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer NCT06478225NA1 site📍 Shanghai RenJi Hospital · Tests: BGT007H Cell Injection Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors NCT05797168Phase 1, Phase 260 sites📍 Duarte📍 Irvine📍 La Jolla AstraZeneca · Tests: Torvutatug samrotecan, Saruparib, Bevacizumab, Carboplatin, Palacaparib Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures NCT07299474NA1 site📍 Los Angeles Cedars-Sinai Medical Center · Tests: Lavender Aromatherapy, Placebo Aromatherapy Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma NCT06013618Phase 21 site📍 Guangzhou Sun Yat-Sen University Cancer Center · Tests: Naxitamab monotherapy, GM-CSF, Irinotecan, Temozolomide, Naxitamab in combination therapy GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma NCT05047510NA2 sites📍 Zhuhai📍 Luzhou Chinese Academy of Sciences · Tests: Anti-GPC3-IRDye800CW A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma NCT05967182Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Pembrolizumab, Gemcitabine, Cisplatin A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) NCT07231952Phase 29 sites📍 Boston📍 Boston📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Pirtobrutinib, Venetoclax, Rituximab Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema NCT06710249Phase 21 site📍 Lund Peter Siesjö · Tests: Salovum/SPC flakes MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide MELanoma Brain Metastasis Treated With CYberknife NCT07691255n/a2 sites📍 Milan📍 Milan European Institute of Oncology Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative Chemotherapy NCT06780735NA1 site📍 Goyang-si National Cancer Center, Korea · Tests: The margin-positive rate using the localization technique Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses NCT05674825Phase 1, Phase 21 site📍 Milwaukee Medical College of Wisconsin · Tests: Targeted agent, Standard of care agent Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients NCT07631650Phase 21 site📍 Pittsburgh Matthew Spector · Tests: Bevonescein (ALM 488) Infusion An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response NCT04796818NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Diffusion Weighted Imaging Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer NCT05751018Phase 21 site📍 Beijing Peking Union Medical College Hospital · Tests: Pyrotinib Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies NCT07064018Phase 1, Phase 21 site📍 Orange University of California, Irvine · Tests: Spedox-6, Pegfilgrastim, Filgrastim Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC NCT07138716NA1 site📍 Beijing Luo Yaping · Tests: 68Ga-DOTA-CCK-FS PET/CT H. Pylori Screen-and-treat Study in a Population of Young Adults NCT06275204n/a7 sites📍 Zagreb📍 Rijeka📍 Dublin University of Latvia · Tests: Bismuth-based quadruple therapy, Levofloxacin-based quadruple therapy, Standard triple therapy, Levofloxacin-based trip… The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy NCT06981026NA1 site📍 Olomouc University Hospital Olomouc · Tests: Telemedicine-based prehabilitation and postoperative rehabilitation protocol, including physical activity monitoring, r… Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC NCT04615143Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Tislelizumab, Tislelizumab combined with Levatinib Identification of Therapeutic Targets in Metastatic Gastric Cancer NCT07551440n/a1 site📍 Hong Kong Chinese University of Hong Kong Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors NCT07106814EARLY Phase 11 site📍 Hefei Anhui Provincial Hospital · Tests: Metabolically Armed TIL cells Current Practice of Ventilation Strategies in Children Undergoing General Anesthesia NCT06166706n/a4 sites📍 Perth📍 Genoa📍 Amsterdam Academisch Medisch Centrum - Universiteit van Amsterdam (AM… Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study) NCT06218433NA2 sites📍 Vancouver📍 Tampere Tampere University Hospital · Tests: Urothelial cancer screening using urine tumor DNA test, Urothelial cancer screening using urine cytology (comparator) Single-fraction APBI for Early-stage Breast Cancer With Favorable Histological Subtypes (Breast-1F) NCT06946238NA1 site📍 Milan IRCCS San Raffaele · Tests: Adjuvant single-fraction accelerated partial breast irradiation Molecular Genetics Studies of Cancer Patients and Their Relatives NCT04185935n/a42 sites📍 Phoenix📍 Concord📍 Duarte City of Hope Medical Center · Tests: Biospecimen Collection, Questionnaire Administration Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma NCT03937635Phase 3748 sites📍 Birmingham📍 Anchorage📍 Anchorage ECOG-ACRIN Cancer Research Group · Tests: Daratumumab, Dexamethasone, Lenalidomide, Quality-of-Life Assessment, Questionnaire Administration
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy